-
Innovation Ranking
NewInnovation Ranking – Sleep Number Corp
Sleep Number Corp (Sleep Number) is a manufacturer and provider of sleep beds, related products and technology. The company’s product portfolio includes beds, bedding products, and designs and markets adjustable-firmness beds and other sleep-related accessories. Sleep Number markets products under Sleep Number Sleep Number, Select Comfort, SleepIQ, the Double Arrow logo, AirFit, Bam LABS and other brand names. The company owns and operates retail stores under the Sleep Number banner across the US. It also sells products through its online...
-
Product Insights
NewLikelihood of Approval Analysis for Sleep Apnea
Overview How likely is it that the drugs in Sleep Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sleep Apnea Overview Sleep apnea, a prevalent condition, involves the recurrent interruption...
-
Product Insights
NewLikelihood of Approval Analysis for Sleep Disorders
Overview How likely is it that the drugs in Sleep Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sleep Disorders Overview Sleep disorders encompass a range of conditions affecting the...
-
Product Insights
NewLikelihood of Approval Analysis for Obstructive Sleep Apnea
Overview How likely is it that the drugs in Obstructive Sleep Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obstructive Sleep Apnea Overview Obstructive sleep apnea (OSA) is defined by...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elinzanetant in Sleep Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elinzanetant in Sleep Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elinzanetant in Sleep Disorders Drug Details: Elinzanetant is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Lemborexant in Sleep Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lemborexant in Sleep Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lemborexant in Sleep Disorders Drug Details: Lemborexant (E-2006 / Dayvigo) is n-arylamide/carboxamide derivative...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-4728 in Sleep Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-4728 in Sleep Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-4728 in Sleep Disorders Drug Details: BI-1467335 (PXS-4728) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danavorexton in Obstructive Sleep Apnea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danavorexton in Obstructive Sleep Apnea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danavorexton in Obstructive Sleep Apnea Drug Details: Danavorexton is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AD-817 in Obstructive Sleep Apnea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AD-817 in Obstructive Sleep Apnea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AD-817 in Obstructive Sleep Apnea Drug Details: AD-817 is under development...
-
Product Insights
Sleep Apnea – Drugs In Development, 2023
Global Markets Direct’s, ‘Sleep Apnea - Drugs In Development, 2023’, provides an overview of the Sleep Apnea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sleep Apnea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...